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ABSTRACT 
Objective: The study was designed as formulation, standardization, and evaluation of polyherbal dispersible tablet prepared for the management of 
kidney disorders. To overcome the problem of dyspepsia in geriatric patients by the use of polyherbal dispersible tablets. 
Methods: Dispersible tablets were prepared using aqueous root extract powder of the selected plant viz. A. officinalis, B. diffusa, C. papaya, C. fistula, 
C. intybus, F. hispida, F. indica, C. nurvala, S. virgaurea, and V. negundo with the help of superdisintegrant addition technique using crospovidone, 
sodium starch glycolate and croscarmellose sodium in different percentage. Evaluation assessments such as the substantial test, weight variation, 
hardness, friability, content uniformity, disintegration, in vitro dispersion, stability study and IR compatibility were carried out. 
Results: Micromeritics of extracts powder were determined for all formulation, which signifying good flow properties. The substantial examination 
was established, which comply with official requirements for uniformity test, and the drug content was close to 100% in all formulations. 
Disintegration time was observed for all formulation in which the polyherbal formulation-3 (PHF-3) showing 1.10±0.10 min; during in 
vitro dispersion time, all formulation showed appropriate dispersion in which the PHF-3 captivating 2.00±0.45 min only. The IR compatibility shows 
none chemical interaction between the extracts and excipients. 
Conclusion: The PHF-3 showed satisfactory disintegration and in vitro dispersion time due to crospovidone and reported as the best formulation. 
The stability study and IR compatibility validate the PHF may represent new easily swallow dispersible tablet that may enhance drug permeability 
and advance bioavailability for nephrotic patients. 
Keywords: Polyherbal dispersible tablet, Micromeritics, Dispersion time, Superdisintegrants, Crospovidone, IR compatibility 




The current trends for surviving long and healthy life entirely dependent 
on 
The combination of various herbs (polyherbal) in a particular ratio 
will give a desirable therapeutic effect because the potent 
phytochemical constituents of individual plants are inadequate to 
achieve the beneficial effect [4, 5]. The polyherbal formulation 
contains two or more herbs with different phytoconstituents 
possessing similar or dissimilar therapeutic potential have been 
collectively producing desirable effects during the management of 
human ailments [6, 7]. The popularity of the polyherbal formulation 
is outstanding because of their wide therapeutic range i.e., effective 
at a low dose and safe at high dose, though produces fewer side 
effects whilst misused [8, 9]. 
the traditional medication systems in which Ayurveda is one of the 
most favorable systems because of it possess several natural elements to 
eliminate the critical causes of the disease by restoring the equilibrium 
and preventing further reoccurrence [1]. WHO estimated that around 
80% of the world’s populations still trusting in traditional or Ayurvedic 
medicines for their healthy survival of life [2]. The Indian philosophy 
behind Ayurveda is to prevent unnecessary suffering of survival when 
curing the human ailments and also well-known for the significant 
biodiversity centers through concerning 45,000 herbal plant species out 
of which about 15,000 medicinal plants have been recorded to curing 
different human ailments by using single or multiple herbs for the 
complete elimination of disease [3].  
The various parts used in the Ayurvedic medicine are the seed, root, 
bark, stem, gum, leaves, flowers, fruit, etc. of the plants [10, 11]. The 
present research work designed to formulate and evaluate a novel 
polyherbal dispersible tablet containing aqueous root extracts of some 
selected plants possessing active phytoconstituents which were 
scientifically proven for the management of Glomerulonephritis [12]. 
The name of these selected plants for the study viz. Angelica officinalis 
(Umbelliferae), Boerhavia diffusa (Nyctaginaceae), Carica papaya 
(Caricaceae), Cassia fistula (Fabaceae), Cichorium intybus (Asteraceae), 
Ficus hispida (Moraceae), Fumaria indica (Fumariaceae
MATERIALS AND METHODS 
), Crataeva 
nurvala (Capparidaceae), Solidago virgaurea (Asteraceae), and Vitex 
negundo (Verbenaceae). The quantity of drugs used in the formulation 
was considered by their drug tolerance study and effective dose on the 
basis of toxicity studies report. The equal amount of extract powder, 
25 mg has been used in this formulation for preparing polyherbal 
dispersible tablet as active constituents [13, 14]. 
Collection and authentication 
The medicinal plants used in the study were purchased from the 
local market of Khari Baoli, New Delhi, India. Fresh and shade dried 
roots of all selected plants have been authenticated by Botanical 
Survey of India, the Northern regional center 192, Kaulagarh Road, 
Dehradun, Boucher No: BSI/NRC/Tech. (Ident.)/2012-13/755.  
Preparation of extract 
The collected roots of the polyherbal plant were cleaned, dried 
under shade and crushed by a mechanical grinder. The powdered 
roots of each selected plants (1000 g) were poured in distilled water 
until the reach of complete exhaustion. Successive extracts were 
separately filtered by using Whatman filter paper and concentrated 
at an appropriate temperature (40 °C) on a rotary evaporator and 
dried under freeze drier. The percentage yield was found between 
20-25% (w/w) respectively, and the final dried powder was stored 
in a closed container at a cool place [15]. 
Characterization of powder  
The biologically potent polyherbal extract powder with a stand for 
varied physical properties and micromeritic properties. Extract 
powdered are heterogeneous because it was composed of individual 
particles of different sizes and shapes randomly interspersed with 
air spaces and becomes more complicated with polyherbal [16, 17]. 
Measurements were carried out in triplicate for each formulation 
and presented as the average±standard deviation (SD). 
International Journal of Applied Pharmaceutics 
ISSN- 0975-7058                               Vol 11, Issue 1, 2019 
Tirath et al. 
Int J App Pharm, Vol 11, Issue 1, 2019, 158-167 
 
159 
Angle of repose 
The flow properties of thoroughly mixed all polyherbal extract 
powder in the formulation were determined by calculating the angle 
of repose by the fixed height method. A funnel with 10 mm in 
diameter of the bottom was fixed at the height of 2 cm over the plain 
and smooth surface. About 10 gm of a thoroughly mixed sample was 
slowly passed beside the wall of the funnel until the tip of the pile 
formed and touches the bottom of the funnel. A rough circle 
drowned around the pile base, and the radius of the powder cone 
was measured [18]. The angle of repose was calculated by the 
average radius using the following formula given as eq. 1. 
 ……. (1) 
Where, 
θ = angle of repose 
h = height of the pile 
r = average radius of the powder cone 
Bulk density 
The bulk densities (BD) of polyherbal powder mixture were 
determined by pouring gently 25 gm of sample mixture through a 
glass funnel into a 100 ml graduated cylinder. The initial volumes 
occupied by the sample were recorded. The bulk density was 
calculated by using the following formula given as eq. 2. 
 
 ……… (2) 
Tapped density 
The tapped densities (TD) of polyherbal powder mixture were 
determined by pouring gently 25 gm of sample mixture through a 
glass funnel into a 100 ml graduated cylinder. The cylinder was 
tapped from the height of 2 inches until a constant volume obtained 
and then the average value of all formulation reported. The final 
volume occupied by the sample after tapping were recorded and 
tapped density calculated by using the formula given as eq. 3. 
 
 ………. (3) 
Compressibility 
The Carr's compressibility gives a useful empirical guide. The 
compressibility of the polyherbal powder mixture was calculated by 
comparing the bulk density and tapped density. The percentage 
compressibility of all formulation was calculated as eq. 4. 
 
 …….. (4) 
Hausner’s ratio 
It also shows densification of herbal powder mixture which may 
result from the vibration of the feed hopper, which was calculated by 
using the formula given in eq. 5. 
 
Polyherbal dispersible tablets were prepared separately through 
geometrical dilution mixture with direct compression method 
(Punching machines, Cadmach CMS-15 No. H/513/11-12) by using 
different ingredients, disintegrating agents, talc, etc. as the 
composition of these formulations and denoted by PHF-1 to PHF-9. 
All the ingredients were passed through a mesh sieve no. 120 and 
then mixed each other by using geometrical dilution method to 
maintain uniformity. Powder mixtures possess good flow properties 
and good packing ability; therefore, the mixtures were directly 
compressed [20]. 
Evaluation of polyherbal dispersible tablet 
Drug content uniformity test 
From each formulation, 20 tablets were taken, weighed and 
thoroughly triturated. The sufficient powder equivalent to 250 mg of 
the drug was accurately weighed and diluted in 300 ml of 0.1N HCl 
for 10 min with vigorous shaking. Further, this prepared mixture 
was diluted with 0.1N HCl to produce 400 ml and then filtered. 10 ml 
of this filtrate was diluted to 100 ml with distilled water, and the 
absorbance was measured at an appropriate wavelength, i.e., λ
……… (5) 
Lower Hausner’s ratio-Better flowability, Higher Hausner’s ratio-
Poor flowability [18, 19].  
Preparation of polyherbal dispersible tablet 
max 
200-400 nm using UV spectrophotometer [21].  
Disintegration time 
From each formulation 6 polyherbal dispersible tablets were 
randomly selected to determine the disintegration time. The acidic 
buffer (pH 1.2) used as disintegration medium and temperature was 
maintained at 37±0.5 °C. The average disintegration time of six 
tablets was noted down for calculation [22]. 
Dispersion time 
In vitro dispersion time of polyherbal dispersible tablet was 
measured by dropping the tablet in a beaker containing 100 ml of 
normal water. Two tablets from each formulation were randomly 
selected and in vitro dispersion time was determined. A smooth 
dispersion was produced, which passes through a sieve screen with 
a nominal mesh aperture of 710 µm [23, 24].  
In vitro dissolution study 
The dissolution testing of polyherbal medicines become difficult to 
oversee authority requirements due to widely varying constituents. 
The ingredients of polyherbal medicinal products often cover a 
mixture of multiple herbal constituents; dissolution method 
development is much more complex than for defined single 
constituent [25]. 
Stability studies 
Accelerated stability study was carried out as per ICH guidelines for 
polyherbal combination to check the physical, chemical and 
physiological property
RESULTS AND DISCUSSION 
 of prepared formulation in a short period. 
The optimized PHF was subjected to accelerated stability studies at 
three different conditions of temperature and relative humidity i.e., 
25 °C/60% RH, 30 °C/65% RH and 40 °C/75% RH for 3 mo [26]. 
FTIR analysis of polyherbal combination 
Fourier transform infrared (FTIR) spectrum of herbal extracts was 
subjected to determine the identification of the compound and 
compatibility of the drug with other excipients used in the 
formulation of polyherbal dispersible tablets. The spectrum of IR 
helps in the identification of a compound based on the existence of 
different functional groups [27, 28].  
Characterization of powder 
The basic characterization of powder and micromeritic properties of 
formulations containing polyherbal aqueous root extracts powder 
used for preparing dispersible tablets mentioned in table 1. 
Formulation and characterization of tablets 
Polyherbal dispersible tablets were compressed each of 550 mg 
weight on a 10-station Mini Press-I rotary tablet compression 
machine fitted with 12 mm punches size. None tablet 
manufacturing defects like capping, lamination, and chipping were 
observed (table 2). 
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Table 1: Micromeritic parameters of polyherbal aqueous root extracts powder 









Repose ( °) 
PHF-1 0.38±0.05 0.53±0.08 28.30 1.39±0.14 26.48±1.02 
PHF-2 0.42±0.04 0.55±0.06 21.82 1.31±0.11 26.24±1.32 
PHF-3 0.35±0.03 0.49±0.07 28.57 1.40±0.13 24.35±1.00 
PHF-4 0.40±0.06 0.50±0.06 20.00 1.25±0.09 30.20±2.01 
PHF-5 0.45±0.04 0.56±0.08 19.64 1.24±0.10 32.12±1.82 
PHF-6 0.38±0.07 0.50±0.07 24.00 1.32±0.08 26.50±1.22 
PHF-7 0.43±0.06 0.52±0.05 17.31 1.21±0.09 27.20±1.65 
PHF-8 0.42±0.05 0.57±0.08 26.32 1.36±0.12 28.32±1.37 
PHF-9 0.40±0.04 0.54±0.06 25.93 1.35±0.14 28.22±1.56 
All values are reported as mean±SD, n=3 measurements. 
 
Table 2: Composition of polyherbal formulation for dispersible tablets 
Ingredients (mg/tab) PHF-1 PHF-2 PHF-3 PHF-4 PHF-5 PHF-6 PHF-7 PHF-8 PHF-9 
Aqueous extracts 



















β-cyclodextrin 200 200 200 200 200 200 200 200 200 
Crospovidone 15 20 25 -- -- -- -- -- -- 
Sod. Starch glycolate -- -- -- 15 20 25 -- -- -- 
Croscarmellose sodium -- -- -- -- -- -- 15 20 25 
Microcrystalline cellulose 65 60 55 65 60 55 65 60 55 
Sodium Saccharin 10 10 10 10 10 10 10 10 10 
Mg. Stearate 5 5 5 5 5 5 5 5 5 
Talc 5 5 5 5 5 5 5 5 5 
Total Weight 550 550 550 550 550 550 550 550 550 
PHF=Polyherbal formulation 
 
All the prepared formulations were subjected for evaluation of 
characteristic parameters like size, shape, color, and appearance. 
The prepared polyherbal dispersible tablets were non-sticky and 
look high-quality. The diameter and thickness of each formulated 
tablets were performed with 20 tablets by using a digital vernier 
scale during the physical study because it permits accurate 
measurements and provides exact information about variations 
between tablets of each formulation (table 3). The visualized the 
color and shape of all tablets were observed directly by naked eyes 
(fig. 1). 
 
Table 3: Physical description of polyherbal dispersible tablets 
S. No. Parameter Result  
1. Color  Yellowish-Brown  
2. Shape  Round, Biconvex  
3. Odor  Characteristic odor 
4. Taste Pleasant taste 
5. Size in mm 
i. Thickness  5.12±0.08 mm  
ii. Diameter  12.17±0.01 mm  
 
 
Fig. 1: Physical appearance of polyherbal dispersible tablets 
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The weight variation of tablets was carried out to ensure that, each 
of the tablets contains the proper amount of drug. The test was 
performed by weighing 20 tablets individually using an analytical 
balance, then calculating the average weight and comparing the 
individual tablet weights (table 4). The percentage weight variation 
is calculated by using the eq. 6. 
…… (6) 
Hardness 
The conformation of tablets for capping, abrasion or breakage under 
storage conditions, transportation, and handling before use depends 
on tablet hardness (kg/cm2
Friability 
). The hardness test was performed by 
using Monsanto hardness tester (Harrison’s). The instrument 
measures the force required to break the tablet when the force 
(Kilogram-force) generated by anvils to the tablet. The tablet was 
placed between two anvils; the force applied to the anvils, and the 
crushing strength that causes the tablet to break was recorded, and 
the crushing strength test was performed on 20 tablets of each 
formulation (table 4). 
The friability test was performed by using tablet friability tester 
(Veego). Twenty tablets of each formulation were weighed and 
tested at a speed of 25 rpm for 4 min (100 rotations). After 
removing of dust, tablets were re-weighed, and friability percentage 
was calculated by the given eq. 7, and the average value of all 
formulation is given in table 4. 
 … (7)
 
Table 4: Physical properties of polyherbal dispersible tablets 
Formulation code Average weight (mg) Weight variation (%) Content uniformity (%) Hardness (kg/cm2 Friability (%) ) 
PHF-1 563.15±9.38 2.34 102.38 2.98±0.13 0.90 
PHF-2 562.40±8.01 2.20 101.25 2.91±0.09 0.82 
PHF-3 563.28±7.78 2.36 105.05 2.99±0.14 0.79 
PHF-4 565.31±8.11 2.71 103.10 3.00±0.12 0.86 
PHF-5 560.80±10.2 1.93 099.85 2.94±0.13 0.90 
PHF-6 563.63±7.40 2.42 101.80 2.95±0.12 0.80 
PHF-7 558.34±7.68 1.22 098.96 2.96±0.16 0.85 
PHF-8 563.18±8.07 2.34 102.00 3.02±0.18 0.78 
PHF-9 564.13±8.78 2.50 099.68 2.97±0.11 0.88 
All values are reported as mean±SD, n=20 tablets. 
 
The maximum weight variation obtained was 2.50%, which falls 
within the acceptable weight variation range, i.e.,±5% hence passed 
the weight variation test. The hardness of prepared tablets was in 
the range of 2.94 to 3.02 kg/cm2, which falls within the limit of not < 
3.0 kg/cm2
The disintegration apparatus used for the study was determined by 
using USP (Electro lab-ED2 SAPO). It contains two basket rack 
assembly. Each basket rack assembly comprises 6 glass tubes that 
are 3 inches long, open at the top and held against 10 mesh screens 
at the bottom. Each tablet was placed in each basket tube, and the 
basket rack was dipped in a 1-L beaker of distilled water. The 37±2 
°C temperature was maintained throughout the study (table 5). 
. None of the tablets showed friability value more than 
0.90% which is less than the ideal limit, i.e., 1%.  
Disintegration time 
Dispersion time 
The dispersion time of polyherbal dispersible tablets was observed 
by placing 2 tablets in 100 ml of water in a beaker and gently stirred 
until dispersed completely. A smooth dispersion was obtained by 
passing through a sieve screen with a nominal mesh aperture (table 
5).
  
Table 5: Disintegration and dispersion time of polyherbal dispersible tablet 
Formulations Disintegration time (Min) Dispersion time (Min) 
PHF-1 02.08±0.62 3.18±0.82 
PHF-2 01.45±0.28 2.30±0.60 
PHF-3 01.10±0.10 2.00±0.45 
PHF-4 02.00±0.45 3.00±0.78 
PHF-5 02.18±0.51 2.50±0.65 
PHF-6 01.55±0.60 2.24±0.58 
PHF-7 02.15±0.55 3.25±0.80 
PHF-8 02.06±0.70 2.55±0.71 
PHF-9 01.50±0.58 3.00±0.82 
All values are reported as mean±SD, n=3 measurements. 
 
Out of all the formulation, PHF-3 has passed the disintegration 
test by taking time i.e., 01.10±0.10 min, which is less than ideal 
limits. The best PHF-3 has shown a good dispersion time and the 
complete dispersion was observed within 2.00±0.45 min only. 
Hence the formulation was passed for the in vitro dispersion 
test. 
 
Table 6: Stability data of the polyherbal dispersible tablet (PHF-3) 
Time % Drug content at different storage conditions 
25 °C and 60 % RH 30 °C and 65 % RH 40 °C and 75 % RH 
1 mo 98.92 99.10 99.30 
2 mo 99.20 98.86 98.92 
3 mo 99.34 98.95 97.67 
Tirath et al. 
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IR compatibility studies 
IR spectrum of the polyherbal formulation was obtained using IR 
spectrophotometer Perkin Elmer at Department of Pharmaceutical 
Science, Bhimtal Campus, Kumaun University, Nainital. The 
potassium bromide was used in preparing samples by disk method, 
and measurement was attempted with the accumulation of 20 scans 
and resonation of 4 cm-1 over the range of 450 to 4000 cm-1
  
 (table 7). 
Table 7: Observed IR peaks of polyherbal extract formulation and their interpretation 
S. No. Plant name Observed peak (cm-1 Group present ) Interpretation 
1.  Angelica officinalis 3290.77 Alkynes group ≡C–H stretching 
1587.00 Aromatic ring C–C=C symmetric stretch 
1360.16 Alkane group –C–H bending 
1014.45 Ester group  C–O stretching 
574.24 Alkyl halide C–Br stretching 
2.  Boerhavia diffusa 3278.20 Alkynes group ≡C–H stretching 
1335.12 Nitro compound N–O asymmetric stretch 
1011.85 Ester group C–O stretching 
574.41 Alkyl halide C–Br stretching 
3.  Carica papaya 3273.45 Alkynes group ≡C–H stretching 
1338.78 Nitro compound N–O asymmetric stretch 
1012.28 Ester group  C–O stretching 
572.23 Alkyl halide C–Br stretching 
4.  Cassia Fistula 3296.59 Alkynes group ≡C–H stretching 
2921.26 Alkane group C–H stretching 
1633.13 Amine group N–H bending 
1338.83 Nitro group N=O bending 
1012.93 Ester group C–O stretching 
573.40 Alkyl halide C–Br stretching 
5.  Cichorium intybus 3274.07 Alkynes group ≡C–H stretching 
1590.00 Amine group N–H bending 
1407.78 Aromatic ring C=C stretching 
1016.67 Ester group C–O stretching 
572.34 Alkyl halide C–Br stretching 
6.  Ficus hispida 3276.15 Alkynes group ≡C–H stretching 
2922.75 Alkane group C–H stretching 
1592.51 Amine group N–H bending 
1364.58 Nitro group N=O bending 
1149.37 Alcohol group C–O stretching 
1017.10 Ether group =C–O–C symmetric stretch 
573.76 Alkyl halide C–Br stretching 
7.  Fumaria Indica 3276.35 Alkynes group ≡C–H stretching 
1338.75 Nitro group N=O bending 
1075.72 Alcohol group C–O stretching 
1013.38 Ether group C–O stretching 
573.42 Alkyl halide C–Br stretching 
8.  Crataeva Nurvala 3287.59 Alkynes group ≡C–H stretching 
1338.87 Nitro group N–O asymmetric stretch 
1015.92 Ether group C–O stretching 
572.06 Alkyl halide C–Br stretching 
9.  Solidago virgaurea 3272.34 Alkynes group ≡C–H stretching 
1340.81 Nitro group N=O bending 
1014.95 Ether group C–O stretching 
573.75 Alkyl halide C–Br stretching 
10.  Vitex Negundo 3281.41 Alkynes group ≡C–H stretching 
1339.35 Nitro group N=O bending 
1012.33 Ether group C–O stretching 
528.05 Carbon skeleton mode C–C–O (for skeleton) 
After the running spectra of significant peaks relating to major functional groups were identified, spectra of the successive sample of all compounds 
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Fig. 5.1: IR spectrum of Angelica officinalis linn aqueous root extract 
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The IR spectrum of Angelica officinalis (fig. 5.1) was observed 
and determines the characteristics of functional groups through 
different peaks i.e., 3290.77 cm-1 for alkynes group (≡C–H 
stretching), 1587.00 cm-1 for aromatic ring (C–C=C symmetric 
stretch), 1360.16 cm-1 for the alkane group (–C–H bending), the 
strong band at 1014.45 cm-1 forester group (C–O stretching), and 
an alkyl halide group (C–Br stretching) found at 574.24 cm-1
 
. 
The IR spectrum of Boerhavia diffusa (fig. 5.2) was observed and 
determines the characteristics of functional groups through different 
peaks i.e., 3278.20 cm-1 for alkynes group (≡C–H stretching), 
1335.12 cm-1 for nitro compound (N–O asymmetric stretch), the 
very strong band observed at 1011.85 cm-1 for the ester group (C–O 
stretching), and the wagging vibration of the alkyl halide group (C–
Br stretching) was observed at 574.24 cm-1
      






















Fig. 5.2: IR spectrum of Boerhavia diffusa linn aqueous root extract 
 
  



















Fig. 5.3: IR spectrum of Carica papaya linn aqueous root extract 
 
      























Fig. 5.4: IR spectrum of Cassia fistula linn aqueous root extract 
 
The IR spectrum of Carica papaya (fig. 5.3) shows different peaks to 
determine the characteristics of functional groups as 3273.45 cm-1 
for alkynes group (≡C–H stretching), the peak at 1338.78 cm-1 was 
assigned as asymmetric for nitro compound (N–O stretch), the 
intensity band at 1012.28 cm-1 corresponds to the ester group (C–O 
stretching), and the strong band observed at 572.23 cm-1
The IR spectrum of Cassia fistula (fig. 5.4) was observed to 
determine the characteristics of functional groups by different peaks 
for alkyl 
halide group (C–Br stretching). 
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viz. the peak observed at 3296.59 cm-1 is assigned to the stretching 
vibration of ≡C–H (alkynes) group. The band in the region around 
2921.26 cm-1 observed for C–H stretching (alkane group), a strong 
peak at 1633.13 cm-1 assigned toward N–H bending vibration 
(amine group). The intensity band at 1338.83 cm-1 for the nitro 
group (N=O bending), a strong peak at 1012.93 cm-1 for an ester 
group (C–O stretching) and the alkyl halide group (C–Br stretching) 
was observed at 573.40 cm-1
 
. 
      
















1590.00cm-1, 94.33%T 572.34cm-1, 94.34%T
1407.78cm-1, 94.46%T
 
Fig. 5.5: IR spectrum of Cichorium intybus linn aqueous root extract 
 
The IR spectrum of Cichorium intybus (fig. 5.5) was observed and 
determines the characteristics of functional groups through different 
peaks i.e., 3274.07 cm-1 for alkynes group (≡C–H stretching), the 
intensity band at 1590.00 cm-1 for N–H (amine) group, the strong 
peak observed at 1407.78 cm-1 for C=C stretching (aromatic ring). 
The peak observed at 1016.67 cm-1 assigned to the stretching 
vibration of C–O (ester) group, and the wagging vibration of the 
alkyl halide group (C–Br stretching) was observed at 572.34 cm-1
 
. 
      





























Fig. 5.6: IR spectrum of Ficus hispida linn aqueous root extract 
 
The IR spectrum of Ficus hispida (fig. 5.6) shows different peaks to 
determine the characteristics of functional groups as 3276.15 cm-1 
for alkynes group (≡C–H stretching), and a strong peak at 2922.75 
cm-1 observed for an alkane group (C–H stretching). The intensity 
band at 1592.51 cm-1 assigned for N–H (amine) group and the strong 
peak observed at 1364.58 cm-1 for N=O bending (nitro group). The 
peak at 1149.37 cm-1 observed for alcohol group (C–O stretching), 
the intensity band at 1017.10 cm-1 was assigned as an asymmetric 
stretch for =C–O–C (ether) group and the strong band observed at 
573.76 cm-1
 
for alkyl halide group (C–Br stretching). 
      


















3276.35cm-1, 92.39%T 573.42cm-1, 92.85%T
1338.75cm-1, 94.55%T
 
Fig. 5.7: IR spectrum of Fumaria indica linn aqueous root extract 
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The IR spectrum of Fumaria indica (fig. 5.7) was observed for 
determining the characteristics of functional groups by different peaks 
viz. the peak observed at 3276.35 cm-1 is assigned to the stretching 
vibration of ≡C–H (alkynes) group. The strong band at 1338.75 cm-1 
observed for N=O bending (nitro group), a strong peak at 1075.72 cm-1 
assigned toward C–O stretching (alcohol group). A strong peak at 
1013.38 cm-1 for the ester group (C–O stretching) and the alkyl halide 
group (C–Br stretching) was observed at 573.42 cm
 
-1. 
      























Fig. 5.8: IR spectrum of Crataeva nurvala linn aqueous root extract 
 
The IR spectrum of Crataeva nurvala (fig. 5.8) shows different 
peaks to determine the characteristics of functional groups as 
3287.59 cm-1 for alkynes group (≡C–H stretching), the peak at 
1338.87 cm-1 was assigned as asymmetric for nitro compound 
(N–O stretch), the intensity band at 1015.92 cm-1 corresponds to 
the ether group (C–O stretching), and the strong band observed 
at 572.06 cm-1
The IR spectrum of Solidago virgaurea (fig. 5.9) was observed and 
determines the characteristics of functional groups through different 
peaks i.e., 3272.34 cm
for alkyl halide group (C–Br stretching). 
-1 for alkynes group (≡C–H stretching), the 
intensity band at 1340.81 cm-1 for N=O (nitro) group. The peak 
observed at 1014.95 cm-1 assigned to the stretching vibration of C–O 
(ether) group, and the wagging vibration of the alkyl halide group 
(C–Br stretching) was observed at 573.75 cm-1
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Fig. 5.9: IR spectrum of Solidago virgaurea linn aqueous root extract 
 
       





















Fig. 5.10: IR spectrum of Vitex negundo linn aqueous root extract 
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The IR spectrum of Vitex negundo (fig. 5.10) was observed for 
determining the characteristics of functional groups by different 
peaks viz. the peak observed at 3281.41 cm-1 is assigned to the 
stretching vibration of ≡C–H (alkynes) group. The strong band at 
1339.35 cm-1 observed for N=O bending (nitro group). A strong peak 
at 1012.33 cm-1 for the ether group (C–O stretching) and the carbon 
skeleton mode (C–C–O) was observed at 528.05 cm-1
The various components of the prepared polyherbal dispersible 
tablet formulations are shown in table 2. The formulation containing 
polyherbal drugs selected for preparing dispersible tablets were 
identified using published standard methods viz. powder 
characteristics, powder micro-meritics, drug content uniformity test, 
disintegration and dispersion time, stability study, and IR 
spectroscopy for drug excipients interaction study [29]. 
Organoleptic properties of prepared polyherbal dispersible tablet 
show the yellowish-Brown in color, almost round with characteristic 
odors and pleasant taste (fig. 1). The average thickness of tablets 
5.12±0.08 mm and average diameter 12.17±0.01 mm was recorded 
during the evaluation and development of tablets (table 3) [30]. 
. 
The micromeritic properties of formulations containing aqueous 
root extracts powder used for preparation of polyherbal dispersible 
tablets observed that, the formulation PHF-3 has passed and shows 
all excellent properties viz. bulk density (0.35±0.03 gm/ml), tapped 
density (0.49±0.07 gm/ml), compressibility (28.57%), Hausner ratio 
(1.40±0.13), and Angle of repose (24.35±1.00 °), which was 
comparable as per IP standard (table 1). PHF-3 has also shows the 
best physical properties i.e. average weight (563.28±7.78 mg), 
weight variation (2.36 %), content uniformity (105.05%), hardness 
(2.99±0.14 kg/cm2
The disintegration time of dispersible tablets containing aqueous 
root extract of best polyherbal formulations PHF-3 was recorded in 
the acidic buffer (1.10±0.10 min) and the dispersion time of the 
same formulation reported as 2.00±0.45 min only rated as best 
formulation as compared to other formulations (table 5). The 
stability study of polyherbal dispersible tablets for three months at a 
different condition was acceptable as per IP standard (table 6), and 
IR spectra of polyherbal formulations containing aqueous root 
extracts confirmed their stability, identity and purity (fig. 5.1 to fig. 
5.10) [31, 32]. 
), and friability (0.79%) as compare to other fast 
dissolving tablets containing aqueous root extract of polyherbal 
formulations (table 4). 
CONCLUSION 
The results from the angle of repose, Carr's index and Hausner’s 
ratio showed that the powder mixtures possess good flow 
properties. The physical properties of PHF-1 to PHF-9 were 
determined for the uniformity in weight, hardness, drug content and 
friability which have complied with the official requirements, and 
comply with the official limits mentioned in IP 2010. The PHF-3 
showed good disintegration property and in vitro dispersion time as 
compare to other formulation. The FTIR spectroscopy suggests that 
the absence of any chemical interaction between the polyherbal 
extract and the excipients used in the dispersible tablet. The stable 
peaks of the drug remained unchanged in the mixtures shows 
characteristic functional groups like alkynes group, aliphatic amines, 
alkyl halides, an aromatic group, alkanes, alcohols, and the ester 
possess the various medicinal properties. The PHF-3 kept for 
stability studies and observed that it was reproducible even on 
stored for three months.  
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